Record Information |
---|
Version | 2.0 |
---|
Created at | 2005-11-16 15:48:42 UTC |
---|
Updated at | 2022-01-20 19:40:07 UTC |
---|
NP-MRD ID | NP0001359 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Glycerol |
---|
Description | Glycerol or glycerin is a colourless, odourless, viscous liquid that is sweet-tasting and mostly non-toxic. It is widely used in the food industry as a sweetener and humectant and in pharmaceutical formulations. Glycerol is an important component of triglycerides (i.E. Fats and oils) and of phospholipids. Glycerol is a three-carbon substance that forms the backbone of fatty acids in fats. When the body uses stored fat as a source of energy, glycerol and fatty acids are released into the bloodstream. The glycerol component can be converted into glucose by the liver and provides energy for cellular metabolism. Normally, glycerol shows very little acute toxicity and very high oral doses or acute exposures can be tolerated. On the other hand, chronically high levels of glycerol in the blood are associated with glycerol kinase deficiency (GKD). GKD causes the condition known as hyperglycerolemia, an accumulation of glycerol in the blood and urine. There are three clinically distinct forms of GKD: Infantile, juvenile, and adult. The infantile form is the most severe and is associated with vomiting, lethargy, severe developmental delay, and adrenal insufficiency. The mechanisms of glycerol toxicity in infants are not known, but it appears to shift metabolism towards chronic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart, liver, and kidney abnormalities, seizures, coma, and possibly death. These are also the characteristic symptoms of untreated GKD. Many affected children with organic acidemias experience intellectual disability or delayed development. Patients with the adult form of GKD generally have no symptoms and are often detected fortuitously. |
---|
Structure | InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2 |
---|
Synonyms | Value | Source |
---|
1,2,3-Propanetriol | ChEBI | 1,2,3-Trihydroxypropane | ChEBI | Glycerin | ChEBI | Glycerine | ChEBI | Glyceritol | ChEBI | Glycerolum | ChEBI | Glycyl alcohol | ChEBI | Glyzerin | ChEBI | Gro | ChEBI | Oelsuess | ChEBI | Propanetriol | ChEBI | Trihydroxypropane | ChEBI | Concentrated glycerin | Kegg | Glycerin, concentrated | Kegg | Bulbold | HMDB | Cristal | HMDB | e 422 | HMDB | Emery 916 | HMDB | Glyceol opthalgan | HMDB | Glyrol | HMDB | Glysanin | HMDB | IFP | HMDB | Incorporation factor | HMDB | Mackstat H 66 | HMDB | Osmoglyn | HMDB | Pricerine 9091 | HMDB | RG-S | HMDB | Tryhydroxypropane | HMDB | 2,5-Dihydroxyphenylacetic acid | HMDB | 2-(3,6-DIHYDROXYPHENYL)acetIC ACID | HMDB | 2,5-Dihydroxyphenylacetate | HMDB | 2-(3,6-DIHYDROXYPHENYL)acetate | HMDB | Homogentisate | HMDB | (2,5-Dihydroxyphenyl)-acetate | HMDB | (2,5-Dihydroxyphenyl)-acetic acid | HMDB | 2,5-Dihydroxy-a-toluate | HMDB | 2,5-Dihydroxy-a-toluic acid | HMDB | 2,5-Dihydroxy-alpha-toluate | HMDB | 2,5-Dihydroxy-alpha-toluic acid | HMDB | 2,5-Dihydroxy-benzeneacetate | HMDB | 2,5-Dihydroxy-benzeneacetic acid | HMDB | Alcapton | HMDB | Homogentisate acid | HMDB | Homogentisinate | HMDB | Homogentisinic acid | HMDB | Melanic acid | HMDB | Acid, homogentisic | HMDB | GlcAa | HMDB | GlcAalpha | HMDB | D-Glucuronate | HMDB | alpha-D-Glucopyranuronic acid | HMDB | alpha-D-Glucuronic acid | HMDB | alpha-delta-Glucopyranuronic acid | HMDB | alpha-delta-Glucuronic acid | HMDB | D-(+)-Glucuronate | HMDB | D-(+)-Glucuronic acid | HMDB | delta-(+)-Glucuronate | HMDB | delta-(+)-Glucuronic acid | HMDB | delta-Glucuronate | HMDB | GCU | HMDB | Glucosiduronate | HMDB | Glucosiduronic acid | HMDB | Glucuronate | HMDB | Glucuronic acid | HMDB | (2E)-2-Butenedioic acid | HMDB | (e)-2-Butenedioic acid | HMDB | e297 | HMDB | Fumarsaeure | HMDB | trans-1,2-Ethylenedicarboxylic acid | HMDB | trans-But-2-enedioic acid | HMDB | trans-Butenedioic acid | HMDB | (2E)-2-Butenedioate | HMDB | (e)-2-Butenedioate | HMDB | trans-1,2-Ethylenedicarboxylate | HMDB | trans-But-2-enedioate | HMDB | trans-Butenedioate | HMDB | Fumarate | HMDB | (2E)-But-2-enedioate | HMDB | (2E)-But-2-enedioic acid | HMDB | 2-(e)-Butenedioate | HMDB | 2-(e)-Butenedioic acid | HMDB | Allomaleate | HMDB | Allomaleic acid | HMDB | Boletate | HMDB | Boletic acid | HMDB | FC 33 | HMDB | Lichenate | HMDB | Lichenic acid | HMDB | Sodium fumarate | HMDB | trans-2-Butenedioate | HMDB | trans-2-Butenedioic acid | HMDB | Furamag | HMDB | Ammonium fumarate | HMDB | Magnesium fumarate | HMDB | Mafusol | HMDB |
|
---|
Chemical Formula | C3H8O3 |
---|
Average Mass | 92.0938 Da |
---|
Monoisotopic Mass | 92.04734 Da |
---|
IUPAC Name | propane-1,2,3-triol |
---|
Traditional Name | glycerol |
---|
CAS Registry Number | 56-81-5 |
---|
SMILES | OCC(O)CO |
---|
InChI Identifier | InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2 |
---|
InChI Key | PEDCQBHIVMGVHV-UHFFFAOYSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, simulated) | Ahselim | | | 2022-01-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 400 MHz, H2O, simulated) | v.dorna83@yahoo.com | Not Available | Not Available | 2021-08-01 | View Spectrum |
| Species |
---|
Species of Origin | |
---|
Species Where Detected | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as sugar alcohols. These are hydrogenated forms of carbohydrate in which the carbonyl group (aldehyde or ketone, reducing sugar) has been reduced to a primary or secondary hydroxyl group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic oxygen compounds |
---|
Class | Organooxygen compounds |
---|
Sub Class | Carbohydrates and carbohydrate conjugates |
---|
Direct Parent | Sugar alcohols |
---|
Alternative Parents | |
---|
Substituents | - Sugar alcohol
- Secondary alcohol
- Polyol
- Hydrocarbon derivative
- Primary alcohol
- Alcohol
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Liquid |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | 20 °C | Not Available | Boiling Point | 181.00 to 182.00 °C. @ 20.00 mm Hg | The Good Scents Company Information System | Water Solubility | 1000 mg/mL | Not Available | LogP | -1.76 | Hansch CH, Leo A and Hoekman DH. "Exploring QSAR: Hydrophobic, Electronic, and Steric Constraints. Volume 1" ACS Publications (1995). |
|
---|
Predicted Properties | |
---|
General References | - Boulat O, Gradwohl M, Matos V, Guignard JP, Bachmann C: Organic acids in the second morning urine in a healthy Swiss paediatric population. Clin Chem Lab Med. 2003 Dec;41(12):1642-58. [PubMed:14708889 ]
- de Araujo Burgos MG, Bion FM, Campos F: [Lactation and alcohol: clinical and nutritional effects]. Arch Latinoam Nutr. 2004 Mar;54(1):25-35. [PubMed:15332353 ]
- Olbermann M, Grunert A, Bassler KH: [Biokinetic characterization of human glycerin utilization]. Infusionsther Klin Ernahr. 1977 Apr;4(2):68-70. [PubMed:558160 ]
- Titov VN, Lisitsyn DM, Ameliushkina VA, Lupanov VP, Staroverov II, Osipov SG, Kukharchuk VV: [Double bonds of fatty acids, alcohols glycerol, cholesterol and nonpolar serum lipids. Diagnostic value of hypercholesterolemia]. Klin Lab Diagn. 2002 May;(5):3-8. [PubMed:12085703 ]
- Konig K, Rickels E, Heissler HE, Zumkeller M, Samii M: Artificial elevation of brain tissue glycerol by administration of a glycerol-containing agent. Case report. J Neurosurg. 2001 Apr;94(4):621-3. [PubMed:11302662 ]
- Fluhr JW, Mao-Qiang M, Brown BE, Wertz PW, Crumrine D, Sundberg JP, Feingold KR, Elias PM: Glycerol regulates stratum corneum hydration in sebaceous gland deficient (asebia) mice. J Invest Dermatol. 2003 May;120(5):728-37. [PubMed:12713573 ]
- Sjostrand M, Gudbjornsdottir S, Holmang A, Strindberg L, Ekberg K, Lonnroth P: Measurements of interstitial muscle glycerol in normal and insulin-resistant subjects. J Clin Endocrinol Metab. 2002 May;87(5):2206-11. [PubMed:11994365 ]
- Sjarif DR, Hellerud C, van Amstel JK, Kleijer WJ, Sperl W, Lacombe D, Sass JO, Beemer FA, Duran M, Poll-The BT: Glycerol kinase deficiency: residual activity explained by reduced transcription and enzyme conformation. Eur J Hum Genet. 2004 Jun;12(6):424-32. [PubMed:15026783 ]
- De Haene H, Taes Y, Christophe A, Delanghe J: Comparison of triglyceride concentration with lipemic index in disorders of triglyceride and glycerol metabolism. Clin Chem Lab Med. 2006;44(2):220-2. [PubMed:16475911 ]
- Eriksson A, Lindstedt S, Ransnas L, von Wendt L: Deficiency of glycerol kinase (EC 2.7.1.30). Clin Chem. 1983 Apr;29(4):718-22. [PubMed:6299616 ]
- Quisth V, Enoksson S, Blaak E, Hagstrom-Toft E, Arner P, Bolinder J: Major differences in noradrenaline action on lipolysis and blood flow rates in skeletal muscle and adipose tissue in vivo. Diabetologia. 2005 May;48(5):946-53. Epub 2005 Mar 19. [PubMed:15778861 ]
- Pecora P, Suraci C, Antonelli M, De Maria S, Marrocco W: Blood glycerol meaning in obese patients. Boll Soc Ital Biol Sper. 1981 Dec 15;57(23):2389-93. [PubMed:7337752 ]
- Berger C, Sakowitz OW, Kiening KL, Schwab S: Neurochemical monitoring of glycerol therapy in patients with ischemic brain edema. Stroke. 2005 Feb;36(2):e4-6. Epub 2004 Dec 23. [PubMed:15618446 ]
- Bulow J, Gjeraa K, Enevoldsen LH, Simonsen L: Lipid mobilization from human abdominal, subcutaneous adipose tissue is independent of sex during steady-state exercise. Clin Physiol Funct Imaging. 2006 Jul;26(4):205-11. [PubMed:16836692 ]
- Yaqoob M, Nabi A: Flow injection chemiluminescent assays for glycerol and triglycerides using a co-immobilized enzyme reactor. Luminescence. 2003 Mar-Apr;18(2):67-71. [PubMed:12687625 ]
- Coppack SW, Chinkes DL, Miles JM, Patterson BW, Klein S: A multicompartmental model of in vivo adipose tissue glycerol kinetics and capillary permeability in lean and obese humans. Diabetes. 2005 Jul;54(7):1934-41. [PubMed:15983192 ]
- Ross SE, Erickson RL, Gerin I, DeRose PM, Bajnok L, Longo KA, Misek DE, Kuick R, Hanash SM, Atkins KB, Andresen SM, Nebb HI, Madsen L, Kristiansen K, MacDougald OA: Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor alpha in adipocyte metabolism. Mol Cell Biol. 2002 Aug;22(16):5989-99. [PubMed:12138207 ]
- Foster KJ, Alberti KG, Hinks L, Lloyd B, Postle A, Smythe P, Turnell DC, Walton R: Blood intermediary metabolite and insulin concentrations after an overnight fast: reference ranges for adults, and interrelations. Clin Chem. 1978 Sep;24(9):1568-72. [PubMed:688619 ]
- Ekberg NR, Wisniewski N, Brismar K, Ungerstedt U: Measurement of glucose and metabolites in subcutaneous adipose tissue during hyperglycemia with microdialysis at various perfusion flow rates. Clin Chim Acta. 2005 Sep;359(1-2):53-64. [PubMed:15939412 ]
- Moon C, Ahn JH, Kim SW, Sang BI, Um Y: Effect of biodiesel-derived raw glycerol on 1,3-propanediol production by different microorganisms. Appl Biochem Biotechnol. 2010 May;161(1-8):502-10. doi: 10.1007/s12010-009-8859-6. Epub 2009 Nov 25. [PubMed:19937397 ]
|
---|